Ghrelin and GHRP-6 Improve Diabetic Gastroparesis by Restoring Stomach Emptying

Ghrelin and GHRP-6 therapeutically improved gastroparesis (delayed stomach emptying) in diabetic rats through gastric motility stimulation — positioning GH secretagogues as diabetic gastroparesis treatments.

Qiu, Wen-cai et al.·Chinese medical journal·2008·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01405Animal StudyPreliminary Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Ghrelin and GHRP-6 restored gastric emptying in streptozotocin-diabetic rats with gastroparesis, improving gastric motility through GHS-R activation — validating GH secretagogues as therapeutic agents for diabetic gastroparesis, a common and debilitating complication.

Key Numbers

How They Did This

animal-study study.

Why This Research Matters

Relevant for ghrp, neuropeptides, gut-healing, diabetes.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Ghrelin and GHRP-6 restored gastric emptying in streptozotocin-diabetic rats with gastroparesis, improving gastric motility through GHS-R activation —
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2008.
Original Title:
Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro.
Published In:
Chinese medical journal, 121(13), 1183-8 (2008)
Database ID:
RPEP-01405

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Ghrelin and GHRP-6 Improve Diabetic Gastroparesis by Restoring Stomach Emptying

What was found?

Ghrelin and GHRP-6 therapeutically improved gastroparesis (delayed stomach emptying) in diabetic rats through gastric motility stimulation — positioning GH secretagogues as diabetic gastroparesis treatments.

Read More on RethinkPeptides

Cite This Study

RPEP-01405·https://rethinkpeptides.com/research/RPEP-01405

APA

Qiu, Wen-cai; Wang, Zhi-gang; Wang, Wei-gang; Yan, Jun; Zheng, Qi. (2008). Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro.. Chinese medical journal, 121(13), 1183-8.

MLA

Qiu, Wen-cai, et al. "Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro.." Chinese medical journal, 2008.

RethinkPeptides

RethinkPeptides Research Database. "Therapeutic effects of ghrelin and growth hormone releasing ..." RPEP-01405. Retrieved from https://rethinkpeptides.com/research/qiu-2008-therapeutic-effects-of-ghrelin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.